EverZom is an exosome biotech company developing treatments for digestive tissue healing like Crohn's fistula and organ regeneration like the kidney and the liver.
Founded in 2019, EverZom is positioned to become the leader of exosome therapeutics, the next wave of innovation for the biotech industry. Exosomes, small vesicles secreted by cells, are increasingly recognized as potent agents for intercellular communication and play a crucial role to treat a wide range of diseases. Winner of the European EIC Accelerator Program, EVerZom aims to be the upcoming pioneer in this new field.
The company has successfully developed a multi-patented platform which enables exosome sourcing, generation, loading, and formulation to create proprietary programs and establish early-stage partnerships in the field of regenerative therapy and oncology.
Company Details
- Employees
- 19
- Founded
- -
- Address
- 45, Rue Des Saints-Pères, Paris,ile-De-France,france
- Phone
- 33678280120
- ni****@****zom.com
- Industry
- Biotechnology
- Website
- https://everzom.com
- Keywords
- extracellular vesicles, exosomes, bioproduction, drug delivery, regenerative medecine, biodrugs, cell culture.
- HQ
- Paris, Ile-de-France
Everzom Questions
Everzom's helpline number is 33678280120
Everzom's website is https://everzom.com
Everzom's LinkedIn profile is https://fr.linkedin.com/company/everzom
Everzom has
19 employees.
View email and phone details for 19
employees at Everzom.
Everzom's industry is
Biotechnology
Everzom's top competitors are
Aqemia,
Whitelab Genomics,
Exopharm Ltd,
Cellectis,
Evora Biosciences,
Healshape,
Evox Therapeutics Ltd,
Exocobio,
Smart Immune,
Treefrog Therapeutics.
Everzom's support email address is nicolas.rousseau@everzom.com
Everzom's categories are Biotechnology
Everzom's founding year is 2019
